Silver Book Fact

Anti-platelet therapy stroke risk reduction

Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.

Antithrombotic Trialistsâ?? Collaboration. Collaborative Meta-Analysis of Randomised Trials of Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke in High Risk Patients. BMJ. 2002; 324(7329): 71-86. http://www.bmj.com/content/324/7329/71.full

Reference

Title
Collaborative Meta-Analysis of Randomised Trials of Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke in High Risk Patients
Publication
BMJ
Publication Date
2002
Authors
Antithrombotic Trialistsâ?? Collaboration
Volume & Issue
Volume 324, Issue 7329
Pages
71-86
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.
     
  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.  
  • Death rates from stroke have decreased from 180.7 per 100,000 persons in 1950, to 56.2 per 100,000 persons in 2002.  
  • Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a…  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.